Latest APGI News
Pancreatic Cancer ACCENT Trial Reports Promising Patient Outcome
A significant development has emerged from the ACCENT pancreatic cancer clinical trial sponsored by Amplia Therapeutics in collaboration with Professor Paul Timpson at the Garvan Institute of Medical Research, two patients have achieved a pathological complete...
Promising new research identifying target involved in spread of Pancreatic Cancer
Researchers at the Garvan institute have published findings revealing a promising new therapeutic target to slow down or inhibit metastasis in pancreatic cancer. The study identified a metabolic signaling molecule involved in facilitating the spread of the disease to...
Cancer Council awards funding to Pancreatic Cancer research project identifying promising new treatment target
Prof Paul Timpson, head of the Invasion and Metastasis Lab, Professor Thomas Cox and Dr Brooke Pereira of the Garvan Institute of Medical Research were awarded funding from the Cancer Council to continue research into advancing treatment options for pancreatic cancer....
Other News
Contact APGI
Australian Pancreatic Cancer Genome Initiative
The Kinghorn Cancer Centre
Garvan Institute of Medical Research
370 Victoria St, Darlinghurst
NSW 2010
Australia
On Twitter